The global albumin market attained a value of USD 5.3 billion in 2021. The market is further expected to grow in the forecast period of 2023-2028 at a CAGR of 5.24% to reach nearly USD 7.2 billion by 2027.
The increasing prevalence of fatal diseases related to liver and cardiac disorders that cause hypoalbuminemia are driving the growth of the market. The human serum albumin segment holds a significant share in various therapeutic and non-therapeutic applications owing to robust pharmaceutical research and development (R&D) exploring the several benefits of HSA.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
HSA is a protein secreted by the liver and is known to bind with nitric oxide and regulate inflammatory pathways, along with maintaining plasma colloid oncotic pressure. Human serum albumin is widely considered as a plasma replacement therapy, which is a key factor propelling the growth of the market. In addition, the commercial applications of HSA in drug delivery, vaccine ingredients, sealant in surgeries, and coatings for medical equipment are gradually gaining momentum and increasing the market growth. Furthermore, human serum albumin is popularly used in clinical applications for treating burns, shocks, and blood loss. These are some of the factors boosting the overall growth of the market.
Moreover, the market has been benefitting from the research aimed at discovering the benefits of human serum albumin on COVID-19 affected patients in the historical years.
Albumin refers to a protein secreted and circulated by the liver of humans and bovines and is considered as the most abundant protein found in the blood plasma. It serves the crucial purpose of transporting hormones, enzymes, and vitamins throughout the body.
On the basis of type, the market can be divided into:
Based on application, the market can be classified into:
The EMR report looks into the regional markets of albumin like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The market growth of albumin is expected to be driven by the rising research and development (R&D) activities for expanding the applications and uses of bovine, human, and recombinant serum albumin. The rising awareness regarding albumin procedure and improvements in protein purification and molecular separation technology is projected to provide impetus to the market growth in the coming years. Furthermore, the growing use of nanotechnology for drug delivery is anticipated to positively influence the usage of albumin serum as a nano-carrier in drug delivery and other pharmaceutical applications owing to its non-toxic, biocompatible, and biodegradable properties. Hence, these are some of the factors contributing to the overall market growth of albumin.
The report presents a detailed analysis of the following key players in the global albumin market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Type||
|Breakup by Application||
|Breakup by Region||
|Report Price and Purchase Option||Explore our purchase options that are best suited to your resources and industry needs.|
|Delivery Format||Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Albumin Market Overview
3.1 Global Albumin Market Historical Value (2016-2022)
3.2 Global Albumin Market Forecast Value (2023-2031)
4 Global Albumin Market Landscape
4.1 Global Albumin Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Albumin Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by Region
5 Global Medical Cannabis Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Albumin Market Segmentation
6.1 Global Albumin Market by Type
6.1.1 Market Overview
6.1.2 Bovine Serum Albumin
6.1.3 Human Serum Albumin
6.1.4 Recombinant Serum Albumin
6.2 Global Albumin Market by Application
6.2.1 Market Overview
6.2.2 Drug Delivery
6.2.4 Culture Media Ingredients
6.2.5 Vaccine Ingredients
6.3 Global Albumin Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Albumin Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Albumin Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Albumin Market
9.1 Market Share by Country
10 Latin America Albumin Market
10.1 Market Share by Country
11 Middle East and Africa Albumin Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1 Akron Biotech
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 Takeda Pharmaceutical Company Limited
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 Baxter International, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 Biotest AG
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 Celgene Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Novozymes A/S
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 CSL Behring
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Grifols, S.A.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 Baxalata Incorporated
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 Octapharma AG
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11 Sigma-Aldrich Corporation
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.12 Mitsubishi Tanabe Pharma
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
18 Global Albumin Market- Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
In 2021, the global albumin market attained a value of USD 5.3 billion.
The market is projected to grow at a CAGR of 5.24% between 2023 and 2028.
The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach about USD 7.2 billion by 2027.
The market is being driven by the rising use of human serum albumin for non-therapeutic uses, such as drug development and vaccine ingredients. Also, research aimed at exploring the potential benefits of HSA for the treatment of COVID-19 further accelerated the market growth.
The market growth is expected to be defined by advancements in nanotechnology for the purpose of drug development, along with improvements in protein purification and molecular technologies.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major types of albumin are bovine serum albumin, human serum albumin, and recombinant serum albumin.
The significant applications of albumin include drug delivery, therapeutics, culture media ingredients, and vaccine ingredients, among others.
The major players in the industry are Akron Biotech, Takeda Pharmaceutical Company Limited, Baxter International, Inc., Biotest AG, Celgene Corporation, Novozymes A/S, CSL Behring, and Grifols, S.A., among others.
The global albumin market attained a value of USD 5.3 billion in 2021, driven by the rising benefits of HSA on commercial and therapeutic applications. Aided by advancements in nanotechnology for drug development, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 5.24%. The market is projected to reach about USD 7.2 billion by 2027.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on type, the market can be divided into bovine serum albumin, human serum albumin, and recombinant serum albumin. On the basis of application, the market can be segmented into drug delivery, therapeutics, culture media ingredients, and vaccine ingredients, among others. The major regional markets for albumin are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Akron Biotech, Takeda Pharmaceutical Company Limited, Baxter International, Inc., Biotest AG, Celgene Corporation, Novozymes A/S, CSL Behring, and Grifols, S.A., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Single User License
Five User License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.